RT Journal Article
T1 Persistence as a Robust Indicator of Medication Adherence-Related Quality and Performance.
A1 Menditto, Enrica
A1 Cahir, Caitriona
A1 Malo, Sara
A1 Aguilar-Palacio, Isabel
A1 Almada, Marta
A1 Costa, Elisio
A1 Giardini, Anna
A1 Gil Peinado, María
A1 Massot Mesquida, Mireia
A1 Mucherino, Sara
A1 Orlando, Valentina
A1 Parra-Calderón, Carlos Luis
A1 Pepiol Salom, Enrique
A1 Kardas, Przemyslaw
A1 Vrijens, Bernard
K1 electronic health records
K1 medication adherence
K1 performance indicator
K1 persistence
K1 quality of care
AB Medication adherence is a priority for health systems worldwide and is widely recognised as a key component of quality of care for disease management. Adherence-related indicators were rarely explicitly included in national health policy agendas. One barrier is the lack of standardised adherence terminology and of routine measures of adherence in clinical practice. This paper discusses the possibility of developing adherence-related performance indicators highlighting the value of measuring persistence as a robust indicator of quality of care. To standardise adherence and persistence-related terminology allowing for benchmarking of adherence strategies, the European Ascertaining Barriers for Compliance (ABC) project proposed a Taxonomy of Adherence in 2012 consisting of three components: initiation, implementation, discontinuation. Persistence, which immediately precedes discontinuation, is a key element of taxonomy, which could capture adherence chronology allowing the examination of patterns of medication-taking behaviour. Advances in eHealth and Information Communication Technology (ICT) could play a major role in providing necessary structures to develop persistence indicators. We propose measuring persistence as an informative and pragmatic measure of medication-taking behaviour. Our view is to develop quality and performance indicators of persistence, which requires investing in ICT solutions enabling healthcare providers to review complete information on patients' medication-taking patterns, as well as clinical and health outcomes.
YR 2021
FD 2021-05-03
LK http://hdl.handle.net/10668/17865
UL http://hdl.handle.net/10668/17865
LA en
DS RISalud
RD Apr 7, 2025